Skye Global Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Skye Global Management’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-56,700	Closed	-$102K	–	34
2022 Q4	$102K	Sell	56,700 -171,300	-75%	-$331K	﹤0.01%	19
2022 Q3	$483K	Buy	228,000 +32,500	+17%	+$81.7K	0.01%	20
2022 Q2	$526K	Sell	195,500 -1,000	-0.5%	-$3.72K	0.01%	28
2022 Q1	$853K	Buy	196,500 +86,500	+79%	+$355K	0.01%	28
2021 Q4	$570K	Buy	110,000 +64,500	+142%	+$345K	0.01%	47
2021 Q3	$279K	Buy	45,500 +10,500	+30%	+$83.7K	﹤0.01%	60
2021 Q2	$354K	Buy	35,000 +10,000	+40%	+$108K	0.01%	62
2021 Q1	$345K	Hold	25,000	–	–	0.01%	60
2020 Q4	$271K	Hold	25,000	–	–	0.01%	54
2020 Q3	$271K	Buy	+25,000	New	+$267K	0.01%	71

Other funds holding NAUT

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return

MVG

Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

ACI

Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return

ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Skye Global Management's NAUT Position: Q1 2023 in Review

Skye Global Management sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 56,700 shares — an estimated $102K sold.

Skye Global Management first reported a position in NAUT in Q3 2020 and held it in 10 quarters. The position peaked at $853K in Q1 2022. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

Skye Global Management reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
Skye Global Management sold 56,700 Nautilus Biotechnolgy shares in Q1 2023, an estimated $102K.
Skye Global Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 10 quarters.
Skye Global Management's Nautilus Biotechnolgy position peaked at $853K in Q1 2022.
73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on Skye Global Management's 13F filing for Q1 2023, filed 15 May 2023.